Related Experiment Video
Updated: Jan 21, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.5K
Potential therapeutic drugs for ischemic stroke based on bioinformatics analysis
Lingyan Zhou1, Yuan Wang1, Kun Wang1
1Department of Neurology , The Affiliated Hospital of Qingdao University , Qingdao , China.
The International Journal of Neuroscience
|August 8, 2019
Summary
Researchers identified 20 differentially expressed genes (DEGs) in ischemic stroke (IS) patients, primarily linked to inflammation and immune responses. This study pinpoints potential gene targets and drug molecules for novel ischemic stroke treatments.
Area of Science:
- Genomics
- Molecular Biology
- Pharmacology
Background:
- Ischemic stroke (IS) pathogenesis involves complex genetic and environmental interactions.
- Identifying genetic factors is crucial for understanding and treating IS.
- Gene targets and drug molecules are actively sought for IS therapy.
Purpose of the Study:
- To identify potential gene targets in ischemic stroke (IS) pathogenesis.
- To discover relevant drug molecules for IS treatment.
- To analyze gene expression patterns and interactions in IS.
Main Methods:
- Downloaded and analyzed the GSE16561 microarray dataset.
- Utilized R packages (limma, Ground-Operation Simulation) for DEG analysis and GO annotation.
- Employed STRING and Cytoscape for gene interaction analysis and DGIdb for drug molecule retrieval.
Main Results:
- Identified 20 differentially expressed genes (DEGs) in IS patients (1 downregulated, 19 upregulated).
- Functional enrichment analysis revealed enrichment in inflammatory response and immune response pathways.
- Successfully identified 10 potential drug molecules associated with the identified DEGs.
Conclusions:
- The study identified key biological targets and drug molecules for IS.
- These findings offer potential avenues for novel therapeutic strategies against ischemic stroke.
- Further research can validate these targets and drugs for clinical application.
Related Concept Videos
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
183
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
183
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.1K
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
763
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
763
01:29Therapeutic Drug Monitoring: Affecting Factors
206
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
206
01:16Therapeutic Drug Monitoring: Overview and Classification
318
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
318
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K